Adilson W. Cavalcante

Sarilumab in patients admitted to hospital with severe or critical COVID-19: a randomised, double-blind, placebo-controlled, phase 3 trial

G. Canonica, T. Zander, N. Adhikari, 2021, The Lancet Respiratory Medicine.

Tocilizumab and remdesivir in hospitalized patients with severe COVID-19 pneumonia: a randomized clinical trial

N. Lewin-Koh, I. Rosas, N. Hanania, 2021, Intensive Care Medicine.